MedPath
NMPA Approval

Erlotinib Hydrochloride Tablets

国药准字HJ20240115

October 22, 2024

Drug Information

盐酸厄洛替尼片

片剂

150mg(按C₂₂H₂₃N₃O₄ 计)

化学药品

October 22, 2024

October 21, 2029

Company Information

Applicant Company

Formulation Unit -VII, Plot Nos. P1 to P9, Phase-III, VSEZ, Duvvada, Visakhapatnam District 530046, Andhra Pradesh, India.

Manufacturing Company

Formulation Unit -VII, Plot Nos. P1 to P9, Phase-III, VSEZ, Duvvada, Visakhapatnam District 530046, Andhra Pradesh, India.

© Copyright 2025. All Rights Reserved by MedPath
盐酸厄洛替尼片 - NMPA 批准文号 | MedPath